ODDB.org: Open Drug Database

Sandoz Pharmaceuticals AG - Wyost 120 mg/ 1.7 ml, Injektionslösung

Swissmedic Registration	69944	Sequence	01
Product name	Wyost 120 mg/ 1.7 ml	Description	Injektionslösung
ATC-Classification	M05BX04	ATC-Description	Denosumab
Introduction of Sequence	24.01.2025

Composition

denosumabum 120 mg, sorbitolum 78.9 mg, acidum aceticum glaciale, polysorbatum 20, natrii hydroxidum aut acidum hydrochloridum concentratum q.s. ad pH, aqua ad iniectabile q.s. ad solutionem pro 1.7 ml corresp. natrium 0.5 mg.

Packungsbestandteile

Galenic Form

Injection solution

Excipiens

Active Agent	Dose
Denosumabum	120 mg

Inactive agents	Dose
Acidum Aceticum Glaciale
Natrii Hydroxidum aut Acidum Hydrochloridum Concentratum
Polysorbatum 20
Sorbitol	78.9 mg

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001		PR	PR	A		No

2025	©ywesee GmbH